Delivery Order SPE2DE21D7020-SPE2D626F6543
- Not listed
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $2,249.95 by the Defense Health Agency's Medical Supply Chain division, effective October 24, 2025, with an ultimate completion date of October 31, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and carries no small business set-aside designation. This delivery order is issued against Boston Scientific's existing single-award...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $12,580.66 by the Defense Health Agency's Medical Supply Chain division on October 24, 2025. The contract, designated as a fixed-price agreement with economic price adjustment provisions, is scheduled for completion by October 31, 2025. This delivery order is issued without a small business set-aside, allowing Boston Scientific to compete on an...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $1,104.60 under a Blanket Purchase Agreement with the Defense Health Agency's Medical Supply Chain division. The delivery order, designated as 4569783311 NC EMERGE MR 15MM, is structured as a fixed-price contract with economic price adjustment provisions and carries an ultimate completion date of October 28, 2025. The award was issued without a small business set-aside, allowing...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $7,688.80 by the Defense Health Agency's Medical Supply Chain division on September 29, 2023, with an ultimate completion date of October 6, 2023. This fixed-price delivery order with economic price adjustment was issued against an established Blanket Purchase Agreement (BPA) and carries no small business set-aside designation. The contract represents Boston Scientific's continued role...
- Boston Scientific Corp has been awarded a delivery order valued at $4,774.65 by the Defense Health Agency's Medical Supply Chain division for the delivery of next-generation synthetic medical devices. The contract, awarded on October 22, 2025, with an ultimate completion date of October 29, 2025, utilizes fixed-price pricing with economic price adjustment terms and carries no small business set-aside designation. Performance will take place at Boston Scientific's facility in Marlborough,...
- Boston Scientific Corp, a leading global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $6,909.04 by the Defense Health Agency's Medical Supply Chain division on October 23, 2025. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is for the supply of specialized medical equipment identified as "4569832175 ! BLN 2.5MM 100MM 10MM WOLVERINE MNRL CUT." The delivery order will...
- Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $30,690 under contract 4569877376, designated "MOMENTUM IS1 DF4." This fixed-price delivery order with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division on October 29, 2025, with an ultimate completion date of November 5, 2025. The contract carries no small business set-aside designation, allowing Boston Scientific to compete...
- The Defense Health Agency's Medical Supply Chain division awarded a $4,320 fixed-price delivery order with economic price adjustment to Boston Scientific Corp for NRG EEPROM high-flow equipment (98 cm configuration), with an ultimate completion date of October 31, 2025. This delivery order, issued on October 24, 2025, will be performed in Marlborough, Massachusetts, and represents work under Boston Scientific's existing blanket purchase agreement with the Defense Health Agency. The award...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a fixed-price delivery order with economic price adjustment valued at $4,860 by the Defense Health Agency's Medical Supply Chain division on September 2, 2025. The delivery order, with an ultimate completion date of September 9, 2025, represents a short-duration task order for specialized medical devices or equipment. As a major federal contractor, Boston Scientific supplies...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, was awarded a delivery order valued at $3,155.58 by the Defense Health Agency's Medical Supply Chain division on October 21, 2025. The contract, designated as ROTAPRO OS 2.0 with delivery completion required by October 28, 2025, is structured as a fixed-price agreement with economic price adjustment provisions. This delivery order was issued without a small business set-aside, allowing Boston...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D626F6543Delivery Order
Boston Scientific Corp, headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $4,235.60 by the Defense Health Agency's Medical Supply Chain division. The delivery order, issued on October 29, 2025, with an ultimate completion date of November 5, 2025, is characterized by fixed-price pricing with economic price adjustment terms. This award represents a task order issued against Boston Scientific's single-award Blanket Purchase Agreement with the Defense Health Agency, valued at $750,000 with a ceiling through March 30, 2030, which designates the company as the sole supplier for radiation treatment devices. The contract involves no small business set-aside designation, allowing Boston Scientific to compete on an unrestricted basis in the federal marketplace. This delivery order supports the Defense Health Agency's critical medical supply chain requirements for specialized radiation oncology equipment and devices, consistent with Boston Scientific's established role as the primary provider of Y-90 glass microspheres, radiopharmaceuticals, and related radiation treatment technologies across military healthcare facilities and Veterans Affairs medical centers. The company's extensive experience supplying advanced medical devices to federal healthcare entities, combined with its specialized capabilities in radiation treatment modalities, positions it to fulfill the Defense Health Agency's rapid resupply and operational needs for cancer treatment applications across the defense and veterans healthcare enterprises.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/29/25 |